Hi, what are you looking for?
Jewish Business News
Search results for "Chiasma "
Business
– – Israeli-American privately held biomed company Chiasma announced the pricing of its initial public offering of 6, 365, 000 shares of common stock...
Business
The company will raise $80 million to build a marketing network for its oral acromegaly treatment.
Bio-Tech
"With this financing in place, we are well positioned to advance a portfolio of oral drugs that address unmet needs in orphan indications."
StartUps
Israeli biomed company Chiasma has raised $33.8 million out of a planned total $56.3 million round of fundraising. It plans to use the infusion...
Business
Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX:...
VC, Investments
VC-backed exits reached an outstanding $4.98B – highest in 10 years M&A deals below $1 billion strongest in 10 years – at $7.2...
Blogs
Today I present to you my predictions for Israel’s medical achievements that will take place in the forthcoming new Jewish Year of 5776. They...
Blogs
In the 21st Jun 2015 edition of Israel’s good news, the highlights include: · Three important stomach-related medical developments from Israeli scientists. ·...